The rapid expansion of telehealth during the COVID-19 pandemic forced health systems to implement virtual care infrastructure faster than anyone thought possible. In a matter of weeks, organizations that had spent years deliberating about telehealth rollouts were conducting thousands of virtual visits. That experience taught the industry something important: implementation is possible at speed when the urgency is real. It also taught a harder lesson that many organizations are still processing — speed without strategy creates a different set of problems.
The most common mistake health systems made during rapid telehealth deployment was treating it as a temporary access channel rather than a permanent part of the care delivery model. Platforms were selected for speed of deployment, not for long-term integration capability. Workflows were improvised rather than designed. Clinical protocols for telehealth-appropriate visit types were informal or nonexistent. And when the acute phase of the pandemic passed, organizations were left with telehealth infrastructure that didn’t integrate cleanly with their EHR, didn’t have consistent documentation standards, and didn’t have clear policies for which patients and which visit types were appropriate for virtual care versus in-person.
The second most common mistake — and one that’s still playing out — is failing to analyze telehealth utilization data with the same rigor applied to other service lines. Which visit types have the highest no-show rates in virtual format? Which patient populations are underutilizing telehealth due to technology access barriers, and what interventions have moved that needle? Where is telehealth cannibalizing in-person revenue that would have been captured anyway, and where is it genuinely expanding access? These are answerable questions, but only if organizations are tracking the right metrics and asking them systematically.
On the clinical side, telehealth integration raises scope and quality questions that don’t resolve themselves. Which conditions can be safely and effectively managed via video? What are the documentation requirements for synchronous versus asynchronous telehealth encounters? How do you ensure that patients receiving ongoing virtual care aren’t missing clinical assessments — vital signs, physical exam findings — that would change management? Health systems that haven’t developed explicit clinical protocols for their telehealth programs are operating with inconsistency that creates both quality risk and regulatory exposure.
Anura Health Group approaches telehealth as a clinical operations challenge with a technology component — not the other way around. We work with health systems to evaluate their current telehealth infrastructure against their patient population needs, build clinical protocols that standardize virtual care quality, and align telehealth strategy with broader care delivery goals. That includes workforce implications: telehealth changes how clinician time is used, how panels are managed, and how support staff roles need to be structured.
Telehealth is here to stay, and the regulatory environment — including ongoing Congressional action on Medicare telehealth flexibilities — continues to evolve. Organizations that use this moment to build a mature, well-integrated virtual care model will have a genuine competitive and quality advantage. Those that continue to treat telehealth as an ad hoc accommodation will find themselves continuously behind.
Leave a Reply